Nanose Medical

AI Driven Sensing Technology – Screening at the Frontline

Active Seed Startup Founded 2019-10

Website ↗ LinkedIn

Delivering affordable, accurate point-of-care screening—transforming timely insights into improved risk stratification and better patient outcomes Liver disease (MASLD/MASH) and lung cancer are often fatal because they're detected late, when treatment options are limited. Most solutions are invasive, expensive, or underused, so about 83% of MASLD cases go u…